Pfizer's Dividend Faces Big Questions. Here Are 3 Reasons It Should Survive.

Key Points Pfizer's management remains firmly committed to maintaining the dividend. The company's growth portfolio is performing well. Pfizer's cash stockpile further strengthens its ability to fund dividends. 10 stocks we like better than Pfizer › Pfizer 's (NYSE: PFE) forward dividend yield currently tops 6.2%. You can count the number of S&P 500 (SNPINDEX: ^GSPC) members with higher yields on your fingers -- and have several fingers to spare. Does Pfizer's dividend program face big questions? Absolutely. However, that doesn't mean the drugmaker's dividend is in imminent jeopardy. Here are three reasons Pfizer's dividend should survive. Missed AI’s "Act 1"? Act 2 Could Be 15x Bigger.